Further investigation is justified to clarify the mechanisms underlying this apparent negative influence of insulin on cortical bone development because any tendency for insulin to impair cortical bone development may have important clinical consequences, such as contributing to the excess in fracture risk observed in conditions associated with hyperinsulinemia such as type 2 DM. The gene discussed is INS; the disease is Hyperinsulinemia.